CBD May Reduce Seizures in Treatment-Resistant Epilepsy
Cannabidiol Reduces Drop Seizures in Lennox‑Gastaut Syndrome — Phase 3 Trial Results Summary: A randomized phase 3 trial published in The Lancet found that adding a pharmaceutical formulation of cannabidiol to existing anti‑epilepsy treatments significantly reduced the frequency of drop seizures in people with treatment‑resistant Lennox‑Gastaut syndrome. Source: The Lancet. Key finding Treatment with a … Read more